ANNOUNCED AS TEMPORARYNo
On 9 April 2015, the Polish parliament amended the pharmaceutical law, restricting exports of medicinal products from the country. If blacklisted, these products will not be allowed exported unless permission is obtained from the Regulatory Authority - thus de facto introducing an export license.
Furthermore, the amendment also introduced strict reporting obligations for marketing authorisation holders and warehouses.
The changes are aimed at the increasing "parallel trade" i.e. the resale of Polish medicinal products in other EU member states. The Polish government hopes the amendment will hedge the risk of a shortage in medicinal products, which were intended to be sold and used in Poland but were then exported instead.
The amendment came into force on 12 July 2015.
⚑ Please report this page in case you detect an inaccuracy in its content.